PremiumCompany AnnouncementsGSK wins first global approval for hepatitis B functional cure in Japan2h ago
PremiumCompany AnnouncementsAstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market4d agoAZN
PremiumCompany AnnouncementsAstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors4d agoAZN